About Orbital Therapeutics
Orbital Therapeutics develops RNA-based medicines to treat human disease. The company uses a platform that combines RNA technology, delivery techniques, data analytics, and automation. It aims to produce an extended portfolio of medications.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-A
Global Headquarters
Cambridge, United States
Year Founded
2022
Team Size
11-50
Corporate Status
Acquired by Bristol-Myers Squibb
Tracked Since
Oct 1, 2026
Web & Domain Identity
Official Website
orbitaltx.com
Domain Registered Date
Apr 8, 2022
Social & Network Presence
X / Twitter Profile
Not linked
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Series-A announced
fundraisingfox.com
- Capital Raise
Raised $270,000,000 · Series-A
fundraisingfox.com
- Milestone
Website domain registered
orbitaltx.com
- Milestone
Company founded
Cambridge, United States
Investors & Backers
Abu Dhabi Growth Fund
Agent Capital
Andreessen Horowitz
ARCH Venture Partners
Casdin Capital
EXOR N.V.
Heritage Medical Systems
iGlobe Partners
Invus
Moore Strategic Ventures
Newpath Management
Redmile Group
Rellim Capital Management
Funding History
Series-A
· Aug 3, 2025
Undisclosed fundraisingfox.com
Series-A
· Apr 26, 2023
$270,000,000 fundraisingfox.com
Founders & Leadership
Adam Raff
Senior Vice President, Clinical Development
Work email & phone locked
Unlock →
Carol Suh
Founder
Work email & phone locked
Unlock →
Drew Weissman
Founder
Work email & phone locked
Unlock →
Gene Yeo
Founder
Work email & phone locked
Unlock →
Giuseppe Ciaramella
Founder
Work email & phone locked
Unlock →
Howard Chang
Founder
Work email & phone locked
Unlock →
John Maraganore
Founder
Work email & phone locked
Unlock →
Kristina Burow
Founder
Work email & phone locked
Unlock →
Ravi Majeti
Founder
Work email & phone locked
Unlock →
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026